Unexpected Tigecycline Resistance Among Acinetobacter baumannii Isolates: High Minor Error Rate by Etest

REFERENCES

• Perez F, Hujer AM, Hujer KM, Decker BK, Rather PN, Bonomo RA. Global challenge of multidrug-resistant Acineto-bacter baumannii. Antimicrob Agents Chemother 2007; 51 (10): 3471–84.
   PubMed Web of Science ®Google Scholar
• Livermore DL. Tigecycline: what is it, and where should it be used? J Antimicrob Chemother 2005; 56: 611–614.
   PubMed Web of Science ®Google Scholar
• Rossi F, Andreazzi D. Overview of tigecycline and its role in the era of antibiotic resistance. Braz J Infect Dis 2006; 10 (3): 203–16.
   PubMedGoogle Scholar
• Korten V, Ulusoy S, Zarakolu P, Mete B, Turkish MYSTIC Study Group. Antibiotic resistance surveillance over a 4-year pe-riod (2000-2003) in Turkey: results of the MYSTIC Program. Diagn Microbiol Infect Dis 2007; 59 (4): 453-7.
   PubMed Web of Science ®Google Scholar
• Thamlikitkul V, Tiengrim S, Tribuddharat C. Comment on: High tigecycline resistance in multidrug-resistant Acinetobacter baumannii. J Antimicrob Chemother. 2007; 60 (1): 177–8.
   PubMed Web of Science ®Google Scholar
• Navon-Venezia S, Leavitt A, Carmeli Y. High tigecycline resistance in multidrug-resistant Acinetobacter baumannii- au-thors' response. J Antimicrob Chemother 2007; 60 (1): 178–9.
   Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute (CLSI). Per-formance standards for antimicrobial susceptibility testing; 16th informational supplement. M100—S16. Wayne, PA: CLSI; 2006.
   Google Scholar
• Clinical and Laboratory Standards Institute. (CLSI). Meth-ods for dilution antimicrobial susceptibility tests for bacteria that growth aerobically; Approved Standard- 7th ed. CLSI document M7-A7. Wayne, PA; CLSI; 2006.
   Google Scholar
• National Committee for Clinical Laboratory Standards. Approved guideline M23-A2. Development of in vitro suscepti-bility testing criteria and quality control parameters. 2nd ed. Wayne, PA; NCCLS; 2001.
   Google Scholar
• Mezzatesta ML, Trovato G, Gona F, Nicolosi VM, Nicolosi D, Carattoli A et al. In vitro activity of tigecycline and compara-tors against carbapenem-susceptible and resistant Acinetobacter baumannii clinical isolates in Italy. Ann Clin Microbiol Antimi-crob 2008; 7 (1): 4.
   Google Scholar
• In vitro activity of tigecycline against multiple-drug-resistant, including pan-resistant, gram-negative and gram-posi-tive clinical isolates from Greek hospitals. Antimicrob Agents Chemother 2006; 50 (9): 3166-3169.
   Google Scholar
• Hoban DJ, Bouchillon SK, Johnson BM, Johnson JL, Dowzicky MJ. In vitro activity of tigecycline against 6792 Gram-negative and Gram-positive clinical isolates from the global Tige-cycline Evaluation and Surveillance Trial (TEST program, 2004). Diagn Microbiol Infect Dis 2005; 52: 215–227.
   PubMed Web of Science ®Google Scholar
• Sader HS, Jones RN, Stilwell MG, Dowzicky MJ, Fritsche TR Tigecycline activity tested against 26,474 bloodstream infection isolates: a collection from 6 continents. Diagn Microbiol In-fect Dis 2005; 52: 181–186.
   PubMed Web of Science ®Google Scholar
• Rodloff AC, Leclercq R, Debbia EA, Canton R, Oppen-heim BA, Dowzicky MJ. Comparative analysis of antimicrobial susceptibility among organisms from France, Germany, Italy, Spain and the UK as part of the tigecycline evaluation and sur-veillance trial. Clin Microbiol Infect 2008; 14 (4): 307–14.
   Google Scholar
• In vitro activities of tigecycline (GAR-936) against recently isolated clinical bacteria in Spain. Antimicrob Agents Chemother 2002; 46 (3): 892-5.
   Google Scholar
• Navon-Venezia S, Leavitt A, Carmeli Y. High tigecycline resistance in multidrug-resistant Acinetobacter baumannii. J An-timicrob Chemother 2007; 59 (4): 772–4.
   PubMed Web of Science ®Google Scholar
• Peleg AY, Potoski BA, Rea R, Adams J, Sethi J, Capi-tano B et al. Acinetobacter baumannii bloodstream infection while receiving tigecycline: a cautionary report. J Antimicrob Chemother 2007; 59: 128–131.
   Google Scholar
• Determination of disc breakpoints and evaluation of Etests for tigecycline susceptibility testing by the BSAC method. J An-timicrob Chemother 2007; 60 (4): 770-4.
   Google Scholar
• Bolmström A, Karlsson A, Engelhardt A, Ho P, Petersen PJ, Bradford PA et al. Validation and reproducibility assessment of tigecycline MIC determinations by Etest. J Clin Microbiol 2007; 45 (8): 2474–9.
   Google Scholar
• Hope R, Warner M, Mushtaq S, Ward ME, Parsons T, Liv-ermore DM. Effect of medium type, age and aeration on the MICs of tigecycline and classical tetracyclines. J Antimicrob Chemother 2005; 56: 1042–6.
   PubMed Web of Science ®Google Scholar
• Thamlikitkul V, Tiengrim S. Effect of different Mueller-Hin-ton agars on tigecycline disc diffusion susceptibility for Acineto-bacter spp. J Antimicrob Chemother 2008; 62 (4): 847–8.
   PubMed Web of Science ®Google Scholar
• Bradford PA, Petersen PJ, Young M, Jones CH, Tischler M, O'Connell J. Tigecycline MIC testing by broth dilution requires use of fresh medium or addition of the biocatalytic oxy-gen-reducing reagent oxyrase to standardize the test method. Antimicrob Agents Chemother 2005; 49 (9): 3903–9.
   PubMed Web of Science ®Google Scholar
• Akcam FZ, Kaya O, Basoglu N, Avsar K, Yayli G. E-test minimum inhibitory concentrations for tigecycline against noso-comial Acinetobacter baumannii strains. J Chemother 2007;19 (2): 230–1.
   PubMed Web of Science ®Google Scholar
• Dizbay M, Altuncekic A, Sezer BE, Ozdemir K, Arman D. Colistin and tigecycline susceptibility among multidrug-resistant Acinetobacter baumannii isolated from ventilator-associated pneumonia. Int J Antimicrob Agents 2008; 32 (1): 29–32.
   PubMed Web of Science ®Google Scholar
• Timurkaynak F, ArsIan H, Kurt Azap O, Serin Senger SBa and O, Ozbalikci et al. In vitro activity of tigecycline against resistant micro-organisms isolated from burn patients. Burns 2008; 34 (7): 1033-6.
   PubMed Web of Science ®Google Scholar
• Shakil S, Akram M, Khan AU. Tigecycline: a critical up-date. J Chemother 2008; 20 (4): 411–9.
   PubMed Web of Science ®Google Scholar